advertisement
Home » OCD » Mice/Human Studies Suggest Immune System Influences OCD

Mice/Human Studies Suggest Immune System Influences OCD

In a series of lab and human studies, British researchers have discovered that individuals suffering from obsessive compulsive disorder (OCD) have increased levels of a protein called Immuno-moodulin (Imood) in their lymphocytes, a type of immune cell.

The discovery may be profound as it supports an emerging concept that the immune system may influence mental disorders. Moreover, treatment with appropriate antibodies could therefore be of significant benefit to individuals with some forms of mental disorders.

Using a mice model, scientists at Queen Mary University of London and the University of Roehampton, London, discovered that mice with high levels of this protein were also found to exhibit behaviors that are characteristic of anxiety and stress, such as digging and excessive grooming.

When the researchers treated the mice with an antibody that neutralized Imood, the animals’ anxiety levels reduced.

The findings have led the researchers to file a patent application for the antibody and they are now working with a drug company to develop a potential treatment for human patients.

“There is mounting evidence that the immune system plays an important role in mental disorders,” said Professor Fulvio D’Acquisto, a professor of immunology at the University of Roehampton and honorary professor of Immunopharmacology at Queen Mary University of London.

“And in fact people with auto-immune diseases are known to have higher than average rates of mental health disorders such as anxiety, depression and OCD. Our findings overturn a lot of the conventional thinking about mental health disorders being solely caused by the central nervous system.”

Professor D’Acquisto, who led the research, has published the team’s findings in the journal Brain Behavior and Immunity. D’Acquisto first identified Imood by chance while studying a different protein called Annexin-A1 and the role it plays in autoimmune diseases such as multiple sclerosis and lupus.

He had created transgenic mice to over-express this protein in their T-cells, one of the main cells responsible for the development of autoimmune diseases, but found the mice showed more anxiety than normal.

When he and his team analyzed the genes expressed in the animals’ T-cells, they discovered one gene in particular was especially active. The protein produced from this gene was what they eventually named Immuno-moodulin, or Imood.

When the anxious mice were given an antibody that blocked Imood, their behavior returned to normal in a couple of days.

Next, the researchers tested the immune cells from 23 patients with OCD and 20 healthy volunteers. They found Imood expression was around six times higher in the OCD patients.

Other recent research by scientists elsewhere have also found the same protein may also play a role in Attention-Deficit/Hyperactivity Disorder.

D’Acquisto believes Imood does not directly regulate brain functions in a classical way, that is by changing the levels of chemical signals in neurons. Instead, it may influence genes in brain cells that have been linked to mental disorders like OCD.

“This is work we still have to do to understand the role of Imood,” he said. “We also want to do more work with larger samples of patients to see if we can replicate what we saw in the small number we looked at in our study.”

In the meantime, Professor D’Acquisto and Dr. Dianne Cooper, a Senior Lecturer at Queen Mary University of London, are working with the biopharmaceutical company UCB to develop antibodies against Imood that can be used in humans and to understand how this could be used to treat patients with mental disorders.

“It is early still, but the discovery of antibodies — instead of the classical chemical drugs — for the treatment of mental disorders could radically change the life of these patients as we foresee a reduced chance of side effects,” he said. Professor D’Acquisto estimates it could take up to five years before a treatment can be taken to clinical trials.

Source: Queen Mary University of London

Mice/Human Studies Suggest Immune System Influences OCD

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2020). Mice/Human Studies Suggest Immune System Influences OCD. Psych Central. Retrieved on May 30, 2020, from https://psychcentral.com/news/2020/05/01/mice-human-studies-suggest-immune-system-influences-ocd/155911.html
Scientifically Reviewed
Last updated: 1 May 2020 (Originally: 1 May 2020)
Last reviewed: By a member of our scientific advisory board on 1 May 2020
Published on Psych Central.com. All rights reserved.